Sysmex Receives in Vitro Diagnostic Approval for ... | 合法醫療器材資訊網
2015年8月27日—...inindividualcountriesafterreceivingregulatoryapproval).NHIpoints:50(Japan).Relatedproducts:RevohemArachidonicAcid,Revohem ...
Aug. 27, 2015
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announced today the in vitro diagnostic approval for manufacturing and sales of three platelet aggregation agonist reagent kits for use in the hemostasis field with AUTOMATED BLOOD COAGULATION ANALYZER CS-5100/2500/2400/2100i/2000i. This reagent kit allows automation of platelet aggregation testing with increased efficiency and standardization.
The human body prevents blood loss through coagulation. Meanwhile, the body maintains a fine balance between coagulation to prevent blood from clotting too much and fibrinolysis which dissolves clots. Upset of this balance can result in thrombotic diseases, such as myocardial and cerebral infarction. In 2012, the world’s leading cause of death* was ischemic heart disease, with cerebral emboli...
201703 | 合法醫療器材資訊網
Introduction and Evaluation of Light Transmission Platelet ... | 合法醫療器材資訊網
Introduction and Evaluation of Light Transmission — Platelet ... | 合法醫療器材資訊網
Sysmex Receives in Vitro Diagnostic Approval for ... | 合法醫療器材資訊網
Sysmex Receives in | 合法醫療器材資訊網
Sysmex Receives in | 合法醫療器材資訊網
The Basic Evaluation of Light Transmission Platelet ... | 合法醫療器材資訊網
“希森美康”花生四烯酸檢測試劑“SYSMEX” Revohem Arachidonic ... | 合法醫療器材資訊網
【“希森美康”花生四烯酸檢測試劑】許可證字號:衛部醫器輸字第031996號
器材品名:“希森美康”花生四烯酸檢測試劑許可證字號:衛部醫器輸字第031996號註銷狀態:註銷日期:註銷理由:有效日期:2023/12/28...